Investment Management of Virginia’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $11.4M | Sell |
71,711
-33,722
| -32% | -$5.16M | 2.17% | 6 |
|
|
2022
Q4 | $17M | Sell |
105,433
-1,253
| -1% | -$192K | 3.34% | 2 |
|
|
2022
Q3 | $14.3M | Sell |
106,686
-1,345
| -1% | -$193K | 3.1% | 2 |
|
|
2022
Q2 | $16.5M | Sell |
108,031
-8,206
| -7% | -$1.25M | 3.41% | 1 |
|
|
2022
Q1 | $18.8M | Sell |
116,237
-3,725
| -3% | -$541K | 3.31% | 1 |
|
|
2021
Q4 | $16.2M | Sell |
119,962
-353
| -0.3% | -$41.7K | 2.62% | 4 |
|
|
2021
Q3 | $13M | Sell |
120,315
-393
| -0.3% | -$44.9K | 2.49% | 3 |
|
|
2021
Q2 | $13.6M | Sell |
120,708
-694
| -0.6% | -$78.2K | 2.62% | 3 |
|
|
2021
Q1 | $13.1M | Sell |
121,402
-867
| -0.7% | -$92.7K | 2.65% | 4 |
|
|
2020
Q4 | $13.1M | Sell |
122,269
-774
| -0.6% | -$74.4K | 2.85% | 3 |
|
|
2020
Q3 | $10.8M | Sell |
123,043
-5,053
| -4% | -$476K | 2.68% | 4 |
|
|
2020
Q2 | $12.6M | Buy |
128,096
+1,807
| +1% | +$159K | 3.14% | 3 |
|
|
2020
Q1 | $9.62M | Sell |
126,289
-4,036
| -3% | -$344K | 2.92% | 5 |
|
|
2019
Q4 | $11.5M | Sell |
130,325
-2,302
| -2% | -$191K | 2.65% | 6 |
|
|
2019
Q3 | $10M | Buy |
132,627
+1,177
| +0.9% | +$80.7K | 2.47% | 7 |
|
|
2019
Q2 | $9.56M | Sell |
131,450
-18,850
| -13% | -$1.48M | 2.29% | 6 |
|
|
2019
Q1 | $12.1M | Buy |
150,300
+76,187
| +103% | +$6.23M | 1.43% | 19 |
|
|
2018
Q4 | $6.83M | Sell |
74,113
-77
| -0.1% | -$6.77K | 1.77% | 11 |
|
|
2018
Q3 | $7.02M | Sell |
74,190
-617
| -0.8% | -$58.5K | 1.48% | 15 |
|
|
2018
Q2 | $6.93M | Buy |
74,807
+657
| +0.9% | +$64.2K | 1.53% | 15 |
|
|
2018
Q1 | $7.02M | Sell |
74,150
-6,498
| -8% | -$714K | 1.63% | 14 |
|
|
2017
Q4 | $7.8M | Sell |
80,648
-11,433
| -12% | -$1.08M | 1.85% | 12 |
|
|
2017
Q3 | $8.18M | Sell |
92,081
-1,868
| -2% | -$142K | 1.92% | 11 |
|
|
2017
Q2 | $6.81M | Buy |
93,949
+906
| +1% | +$60.9K | 1.64% | 14 |
|
|
2017
Q1 | $6.06M | Sell |
93,043
-340
| -0.4% | -$21.4K | 1.49% | 16 |
|
|
2016
Q4 | $5.85M | Buy |
93,383
+1,240
| +1% | +$75.7K | 1.4% | 20 |
|
|
2016
Q3 | $5.81M | Buy |
92,143
+5,530
| +6% | +$358K | 1.43% | 19 |
|
|
2016
Q2 | $5.36M | Buy |
86,613
+132
| +0.2% | +$8.04K | 1.37% | 20 |
|
|
2016
Q1 | $4.94M | Buy |
86,481
+500
| +0.6% | +$27.9K | 1.3% | 18 |
|
|
2015
Q4 | $5.09M | Sell |
85,981
-1,765
| -2% | -$102K | 1.35% | 20 |
|
|
2015
Q3 | $4.77M | Sell |
87,746
-669
| -0.8% | -$43.5K | 1.26% | 19 |
|
|
2015
Q2 | $5.94M | Sell |
88,415
-5,705
| -6% | -$372K | 1.37% | 15 |
|
|
2015
Q1 | $5.51M | Buy |
94,120
+23,585
| +33% | +$1.42M | 1.25% | 19 |
|
|
2014
Q4 | $4.62M | Sell |
70,535
-2,107
| -3% | -$133K | 0.96% | 31 |
|
|
2014
Q3 | $4.2M | Sell |
72,642
-2,435
| -3% | -$135K | 0.75% | 34 |
|
|
2014
Q2 | $4.24M | Sell |
75,077
-1,075
| -1% | -$56.4K | 0.68% | 42 |
|
|
2014
Q1 | $3.91M | Sell |
76,152
-9,780
| -11% | -$494K | 0.64% | 45 |
|
|
2013
Q4 | $4.54M | Sell |
85,932
-6,539
| -7% | -$321K | 0.75% | 35 |
|
|
2013
Q3 | $4.14M | Sell |
92,471
-1,975
| -2% | -$87.5K | 0.79% | 33 |
|
|
2013
Q2 | $3.9M | Buy |
+94,446
| New | +$4.13M | 0.86% | 31 |
|
Other funds holding ABBV
Investment Management of Virginia's ABBV Position: Q1 2023 in Review
Investment Management of Virginia reduced its AbbVie (ABBV) stake by 32% in Q1 2023, selling an estimated $5.16M and leaving 71,711 shares worth $11.4M. The position accounts for 2.17% of the portfolio, ranked #6.
Investment Management of Virginia first reported a position in ABBV in Q2 2013 and has held it in 40 quarters since. The position peaked at $18.8M in Q1 2022. 3,141 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.
- Investment Management of Virginia held 71,711 shares of AbbVie worth $11.4M as of Q1 2023.
- Investment Management of Virginia sold 33,722 AbbVie shares in Q1 2023, an estimated $5.16M.
- AbbVie made up 2.17% of Investment Management of Virginia's portfolio in Q1 2023, its #6 holding.
- Investment Management of Virginia first reported a position in AbbVie in Q2 2013 and has held it in 40 quarters since.
- Investment Management of Virginia's AbbVie position peaked at $18.8M in Q1 2022.
- 3,141 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.
Based on Investment Management of Virginia's 13F filing for Q1 2023, filed 26 Apr 2023.